Why Fentanyl Mixed With Medetomidine Can Make Withdrawal More Dangerous
A powerful veterinary sedative is appearing in the illicit fentanyl supply, creating new concerns about overdose symptoms and potentially dangerous withdrawal.
The substance is medetomidine, commonly called rhino tranq, mede, or dex. Unlike fentanyl, medetomidine is not an opioid. It can cause profound sedation, dangerously slow heart rates, and low blood pressure. When someone has been exposed repeatedly, stopping it may produce severe withdrawal symptoms that sometimes require emergency or intensive hospital care.
On April 2, 2026, the Centers for Disease Control and Prevention (CDC) issued a national health advisory warning healthcare professionals about medetomidine in the illegal drug supply. The Drug Enforcement Administration (DEA) followed with warnings about fentanyl mixed with emerging synthetic substances, including medetomidine.
Tennessee officials have also confirmed medetomidine in small quantities in the state’s drug supply.
For people in Nashville and Middle Tennessee, the important question is not simply whether they recognize the street name. It is whether someone using fentanyl or another illicit opioid could be exposed to an unexpected sedative—and what type of medical care may be needed if overdose or withdrawal symptoms develop.
If someone is unconscious, breathing abnormally, or experiencing a suspected overdose, call 911 immediately. Give naloxone if available and follow emergency-dispatch instructions.
Table of Contents
What Is Rhino Tranq (Medetomidine)?
Rhino tranq is a street name for medetomidine, a powerful sedative used in veterinary medicine.
Medetomidine belongs to a group of medications known as alpha-2 adrenergic agonists. These substances influence the nervous system and can reduce alertness, heart rate, and blood pressure.
Medetomidine itself is not approved for human use in the United States. A related medication, dexmedetomidine, is used by healthcare professionals for certain types of controlled medical sedation.
In the illicit drug supply, medetomidine has been found mixed with illegally manufactured fentanyl. People exposed to the combination may not know that the sedative is present.
Medetomidine is not another name for fentanyl, heroin, or xylazine. It is a separate substance that can contribute additional medical risks when combined with opioids.
The CDC has reported evidence suggesting that medetomidine found in illicit drug samples is being manufactured outside legitimate pharmaceutical supply chains.
Why Is It Called Rhino Tranq?
The CDC identifies several names used for medetomidine, including:
- Rhino tranq
- Mede
- Dex
- Medetomidine
Street names can vary between communities and change over time. They are not reliable indicators of a product’s actual chemical contents.
The name rhino tranq should also not be confused with tranq, which has commonly referred to xylazine.
Both substances are non-opioid veterinary sedatives, but they are chemically and clinically distinct.
Why Are the CDC and DEA Warning About Medetomidine in Fentanyl?
Medetomidine has become an increasingly recognized component of the illicit drug supply.
According to an April 2026 announcement from the White House Office of National Drug Control Policy and CDC, medetomidine-related law-enforcement seizure records increased from 247 in 2023 to 8,233 in 2025.
These figures reflect reported detections in seized drug evidence. They are not a count of people exposed, overdose deaths, or a measured increase in Tennessee specifically.
Federal agencies report that detections have been concentrated primarily in the Northeast and Midwest, although other parts of the country have also identified the substance.
The DEA’s May 12, 2026, public safety advisory warned that illicit fentanyl was being combined with substances including medetomidine, xylazine, nitazenes, and other emerging synthetic drugs.
On July 2, 2026, the DEA also published intelligence describing medetomidine as a significant emerging adulterant in Indiana.
Together, these reports show why clinicians increasingly need to consider non-opioid sedatives when evaluating an apparent fentanyl overdose or unusually complicated withdrawal.
However, the findings should not be interpreted as proof that every fentanyl sample contains medetomidine or that medetomidine exposure has become equally common throughout the United States.
Primary research: CDC Medetomidine Health Advisory, April 2, 2026
Has Rhino Tranq Been Found in Tennessee?
Yes. Tennessee has documented medetomidine in its illicit drug supply.
According to the Tennessee Department of Mental Health and Substance Abuse Services, the Tennessee Department of Health first confirmed small quantities of medetomidine in East and West Tennessee beginning in 2024.
The state also reported additional suspected samples identified by law-enforcement partners in September 2025. Those particular samples were awaiting laboratory confirmation when described in the state’s emerging-substances resource.
These findings establish that medetomidine is not exclusively a concern in other regions of the country.
They do not establish a newly confirmed outbreak in Nashville, Davidson County, Rutherford County, or Middle Tennessee during November 2026.
For someone using illicit fentanyl, however, geographic uncertainty is itself important: the contents of an unregulated drug product cannot reliably be determined from appearance, street name, or previous experience with the same seller.
Tennessee source: Tennessee Department of Mental Health and Substance Abuse Services — Emerging Substances
What Happens When Fentanyl Is Mixed With Rhino Tranq?
Fentanyl and medetomidine affect the body through different mechanisms.
Fentanyl is a potent synthetic opioid that can suppress breathing and cause life-threatening respiratory depression.
Medetomidine is a non-opioid sedative that can cause profound drowsiness, slow heart rate, and low blood pressure.
When both substances are present, a person may experience overlapping effects that complicate emergency assessment.
Possible Effects of Fentanyl
- Slow, shallow, or absent breathing
- Unresponsiveness or loss of consciousness
- Pinpoint pupils
- Dangerous reductions in oxygen levels
- Blue or gray discoloration of the lips or skin
- Life-threatening overdose
Possible Effects of Medetomidine
- Profound or prolonged sedation
- An unusually slow heart rate
- Low blood pressure
- Reduced alertness
- Difficulty remaining awake
- Altered consciousness
A person exposed to both drugs may continue appearing heavily sedated even after naloxone improves opioid-related breathing suppression.
This does not mean naloxone is ineffective. It means that naloxone does not directly reverse medetomidine’s non-opioid sedative effects.
The distinction is particularly important for emergency responders and clinicians.
What Are the Symptoms of a Rhino Tranq and Fentanyl Overdose?
A suspected overdose involving medetomidine and fentanyl may resemble an opioid overdose, but the additional sedative can complicate the presentation.
Possible warning signs include severe drowsiness, failure to respond to speech or touch, abnormal breathing, slow heart rate, low blood pressure, and persistent unconsciousness.
These symptoms cannot reliably identify medetomidine without appropriate testing and clinical evaluation.
Other substances, medical illnesses, and drug combinations can produce similar symptoms.
What to Do During a Suspected Overdose
If someone may be experiencing an overdose:
Explain that an overdose is suspected and describe the person’s breathing and responsiveness.
Naloxone may reverse the opioid component of an overdose involving fentanyl.
Provide rescue breathing or CPR when instructed and appropriate.
Follow emergency guidance, including recovery-position instructions when indicated, until responders arrive.
Do not assume the person is safe simply because they begin breathing again or regain consciousness.
Do not delay naloxone because you suspect a veterinary sedative is involved.
The CDC specifically recommends administering opioid overdose reversal medication when an opioid may be present, even if medetomidine exposure is suspected.
Does Narcan Work on Rhino Tranq?
Naloxone, commonly known by the brand name Narcan, does not directly reverse medetomidine.
Naloxone works by blocking opioid receptors. It can reverse respiratory depression caused by opioids such as fentanyl, but medetomidine does not act through those same opioid receptors.
Because fentanyl is involved in most reported medetomidine-related overdose cases, naloxone remains an essential emergency intervention.
After administration, someone may begin breathing adequately but remain sleepy because of the non-opioid sedative.
Emergency medical professionals may still need to monitor breathing, heart rate, blood pressure, and consciousness.
It is important not to interpret persistent sedation alone as a reason to give repeated naloxone without considering breathing. The CDC emphasizes restoring adequate breathing as the immediate goal of opioid reversal.
Anyone experiencing a suspected mixed-substance overdose needs emergency medical evaluation.
What Is Rhino Tranq Withdrawal?
One of the most concerning findings in the CDC’s 2026 advisory involves withdrawal after repeated medetomidine exposure.
While intoxication can cause slow heart rate and low blood pressure, withdrawal can produce the opposite pattern.
The body may develop physiological adaptation to repeated exposure. When the sedative is stopped, nervous-system activity can rebound sharply.
The CDC compares this syndrome to withdrawal from certain other alpha-2 agonist medications, such as clonidine.
Reported symptoms include:
- Rapid heart rate
- Severe high blood pressure
- Anxiety or agitation
- Tremors
- Persistent nausea and vomiting
- Chest pain
- Fluctuating alertness or confusion
- Significant autonomic instability
In serious cases, complications can include cardiovascular or neurological injury.
Severe medetomidine withdrawal has required emergency department treatment, hospitalization, and intensive care.
This is why a person who regularly uses illicit fentanyl and unexpectedly develops severe blood-pressure or heart-rate problems after stopping may need evaluation for more than ordinary opioid withdrawal.
How Soon Can Medetomidine Withdrawal Begin?
According to the CDC’s April 2026 advisory, symptoms may begin within hours after the last exposure and can peak approximately 18 to 36 hours later in reported cases.
This is not a reliable self-detox timeline.
The timing and severity of withdrawal depend on exposure history, other substances involved, individual health, and additional clinical factors.
Severe symptoms may require urgent treatment regardless of when the last dose was taken.
Rhino Tranq Withdrawal vs. Fentanyl Withdrawal
Both types of withdrawal can involve nausea, anxiety, sweating, restlessness, and significant discomfort.
However, there are important differences.
| Feature | Fentanyl or opioid withdrawal | Possible medetomidine withdrawal |
|---|---|---|
| Primary mechanism | Opioid dependence and withdrawal | Rebound effects after repeated alpha-2 agonist exposure |
| Common symptoms | Muscle aches, diarrhea, nausea, sweating, anxiety, cravings | Rapid heart rate, severe hypertension, tremors, vomiting, agitation |
| Potential severity | Often highly distressing; complications depend on health and circumstances | Can involve severe autonomic instability and organ complications |
| Treatment considerations | Evidence-based opioid withdrawal management and medications for opioid use disorder | Hospital assessment and potentially intensive monitoring or treatment |
| Can symptoms overlap? | Yes | Yes |
The presence of severe high blood pressure, chest pain, confusion, or persistent vomiting is not something a person should try to classify or treat at home.
These findings require prompt medical assessment.
Someone can also experience opioid withdrawal and medetomidine withdrawal at the same time.
Why Can Mixed Fentanyl Withdrawal Be More Complicated?
When a person has repeatedly used fentanyl contaminated with medetomidine, stopping the drug may involve more than one withdrawal process.
Ordinary opioid withdrawal management may address opioid-related symptoms and cravings, but it does not automatically treat severe autonomic complications caused by medetomidine withdrawal.
Medical teams may need to evaluate several problems simultaneously.
Cardiovascular Instability
Rapid heart rate and severe hypertension can place substantial strain on the cardiovascular system.
Patients with chest pain, severe headache, neurological changes, or other concerning symptoms may require emergency evaluation for complications.
Dehydration and Electrolyte Problems
Severe nausea, vomiting, and poor fluid intake can contribute to dehydration and electrolyte abnormalities.
These conditions may complicate medical stabilization.
Uncertain Drug Exposure
People using unregulated products may not know which substances they have consumed or how often exposure occurred.
This uncertainty can make withdrawal assessment more difficult.
Co-Occurring Substance Dependence
Fentanyl exposure may occur alongside benzodiazepines, alcohol, stimulants, xylazine, or other substances.
Some combinations create additional withdrawal risks that must be considered separately.
For these reasons, a thorough medical and substance-use history is particularly important.
Can You Detox From Rhino Tranq at Home?
Attempting to manage suspected medetomidine withdrawal at home can be dangerous, particularly when symptoms include severe hypertension, chest pain, marked agitation, confusion, or persistent vomiting.
The CDC reports that severe withdrawal has required emergency and intensive care in some affected patients.
There is no established, universally appropriate home-detox method for medetomidine withdrawal.
People should not attempt to manage severe symptoms with someone else’s blood-pressure medication, sedatives, or other prescription drugs.
A healthcare professional may need to assess vital signs, hydration, heart function, possible co-exposures, and other medical concerns before determining the appropriate setting for treatment.
If severe medetomidine withdrawal is suspected, seek emergency or hospital-based care.
A residential detox program should not be assumed capable of managing every complication associated with this emerging substance.
When Is Medical Detox Appropriate After Fentanyl and Rhino Tranq Exposure?
For people with fentanyl dependence, medically supervised opioid withdrawal management may be an important part of entering treatment.
However, the appropriate setting depends on current medical stability and the possibility of additional sedative exposure.
A clinical assessment may consider:
- Which opioids and other substances have been used
- Frequency and duration of use
- Previous overdose events
- Current withdrawal symptoms
- Blood-pressure or heart-rate abnormalities
- Prior seizures, severe withdrawal, or hospitalizations
- Other medical or mental health conditions
- Whether hospital-level stabilization is needed first
After medical stabilization, someone struggling with fentanyl dependence may be eligible for supervised withdrawal care and ongoing addiction treatment based on clinical assessment.
Someone with severe autonomic instability or other potentially life-threatening complications may require emergency or inpatient hospital treatment before entering a residential addiction program.
These are different levels of medical care.
Fentanyl Detox and Addiction Treatment in Nashville
Live Again Detox provides medically supervised drug and alcohol detox in Nashville, Tennessee.
Our fentanyl detox program focuses on individualized withdrawal assessment, medical monitoring, symptom management, and planning for continued addiction treatment.
For people who may have used fentanyl contaminated with another sedative, the admissions and clinical assessment should address possible polysubstance exposure and any unusual withdrawal history.
A patient does not need to know the exact substance name to report that they have experienced prolonged sedation, unusual changes in heart rate, severe vomiting, or dangerous blood-pressure symptoms.
If emergency or hospital-level care is needed, stabilization should occur in that setting before residential treatment is considered.
What Happens During a Detox Assessment?
A clinical assessment may review the following areas.
Substance-use history: The substances used, approximate frequency, recent exposure, previous withdrawal experiences, and any known counterfeit or mixed-drug exposure.
Current medical symptoms: Breathing concerns, heart-rate changes, chest pain, vomiting, hydration, blood-pressure issues, or other urgent problems.
Medication and treatment history: Previous use of medications for opioid use disorder, psychiatric medications, other prescriptions, and prior treatment experiences.
Next level of care: Whether emergency evaluation, hospital stabilization, medically supervised withdrawal management, residential treatment, or another option is clinically appropriate.
Treatment decisions should be based on clinical findings rather than a street name alone.
What Happens After Medical Detox?
Detoxification addresses immediate withdrawal and stabilization needs. It does not, by itself, resolve opioid use disorder or eliminate the risk of another overdose.
For people with fentanyl addiction, ongoing care may include medications for opioid use disorder, counseling, residential treatment, and relapse-prevention support.
Medication for Opioid Use Disorder
Buprenorphine and methadone are established treatments for opioid use disorder.
They may help reduce cravings, support treatment engagement, and lower overdose risk when clinically appropriate.
Medication selection and initiation should be managed by qualified clinicians, particularly when fentanyl exposure or complex withdrawal is involved.
Treatment for opioid use disorder does not replace hospital treatment of severe medetomidine withdrawal.
Residential Addiction Treatment
Some individuals benefit from a structured residential environment after medical stabilization.
Live Again Detox offers residential addiction treatment in Nashville, with individualized therapeutic support and planning for continued recovery.
Mental Health and Continuing Care
People with opioid use disorder may also experience anxiety, depression, trauma-related symptoms, and other mental health concerns.
Coordinated care can address these challenges alongside addiction recovery.
Continuing treatment planning is especially important because opioid tolerance may decline after a period without use, increasing overdose risk if someone returns to previous amounts.
How Families Can Respond to Suspected Rhino Tranq Exposure
Family members may notice that someone using illicit opioids becomes unusually sedated, experiences repeated overdose events, or develops severe symptoms when attempting to stop.
These signs cannot confirm medetomidine exposure, but they should prompt appropriate medical attention.
If the person is experiencing an active overdose, call 911 and give naloxone if available.
If they are awake but experiencing chest pain, severe vomiting, marked confusion, severe headache, or signs of dangerous withdrawal, urgent medical evaluation is appropriate.
After immediate medical concerns have been addressed, family members can help by discussing substance-use treatment without trying to diagnose the exact drug involved.
Useful information to share with clinicians includes recent drug use, timing of the last exposure, previous overdose history, and any known use of other sedatives.
A confidential admissions conversation can help families understand which treatment options may be appropriate once the person is medically stable.
Frequently Asked Questions About Rhino Tranq and Fentanyl
What is rhino tranq?
Rhino tranq is a street name for medetomidine, a veterinary sedative that has been detected in the illicit drug supply, frequently mixed with fentanyl. It is not an opioid and is not approved for human use.
Is rhino tranq the same as xylazine?
No. Medetomidine and xylazine are different veterinary sedatives. Both can appear as adulterants in illicit opioids, but they have different pharmacological characteristics and should not be treated as interchangeable substances.
Does rhino tranq contain fentanyl?
Medetomidine itself does not contain fentanyl. However, it is frequently found mixed with illicit fentanyl, meaning a person may unknowingly be exposed to both substances.
What are the signs of rhino tranq overdose?
Possible effects include profound sedation, slow heart rate, low blood pressure, and altered consciousness. When fentanyl is also involved, dangerously slow or absent breathing may occur. A suspected overdose requires immediate emergency care.
Will Narcan reverse rhino tranq?
Naloxone does not directly reverse medetomidine. It can reverse the opioid component of a mixed overdose involving fentanyl, so it should still be administered when opioid overdose is suspected.
What are medetomidine withdrawal symptoms?
Reported symptoms include severe hypertension, rapid heartbeat, tremors, anxiety, vomiting, chest pain, and fluctuating alertness. Severe cases may require hospitalization or intensive care.
How long does rhino tranq withdrawal last?
The duration varies, and the full clinical course is still being studied. The CDC reports that symptoms may begin within hours and can peak around 18–36 hours after the last exposure. Serious symptoms require medical evaluation rather than waiting for a predicted timeline.
Can you detox from fentanyl and rhino tranq together?
Patients may experience overlapping withdrawal processes when exposed to both substances. The appropriate care setting depends on medical stability. Severe medetomidine withdrawal may require hospital-based treatment, while ongoing opioid dependence may be addressed through evidence-based addiction treatment once clinically appropriate.
Has rhino tranq been found in Tennessee?
Yes. Tennessee officials report confirmed small-quantity detections in East and West Tennessee beginning in 2024. This does not establish a new November 2026 Nashville outbreak or indicate how common exposure is across the state.
Where can I get help for fentanyl addiction in Nashville?
Live Again Detox provides medically supervised fentanyl and opioid withdrawal care in Nashville, along with assessment and planning for continued addiction treatment. Anyone experiencing severe withdrawal complications or an active overdose should receive emergency or hospital-level care first.
Medical Sources and Public-Health References
Centers for Disease Control and Prevention. April 2, 2026. Medetomidine in the U.S. Illegal Fentanyl Supply Increasing Risk for Overdose and Severe Withdrawal Syndrome. Health Alert Network Advisory CDCHAN-00527.
Centers for Disease Control and Prevention. April 2, 2026. Medetomidine Situation Summary. National Center for Injury Prevention and Control.
Drug Enforcement Administration. May 12, 2026. Public Safety Advisory: Heightened Threat — Fentanyl Mixed With Emerging Synthetic Drugs.
Drug Enforcement Administration. July 2, 2026. Medetomidine Emerging as a Significant Adulterant in Indiana.
Tennessee Department of Mental Health and Substance Abuse Services. Emerging Substances: Medetomidine.
Office of National Drug Control Policy and CDC. April 6, 2026. Health Advisory Announcement on Medetomidine in Illicit Fentanyl.
Surveillance reports describe detections and reported cases; they do not establish the frequency of medetomidine exposure in Nashville or identify the contents of an individual drug sample.
Get Help for Fentanyl Dependence in Nashville
The emergence of medetomidine in the illicit fentanyl supply is another reminder that people may be exposed to substances they did not intend to take.
Rhino tranq can complicate overdose symptoms and, after repeated exposure, produce a severe withdrawal syndrome that differs from ordinary opioid withdrawal.
The CDC and DEA have documented increasing concern about this drug combination, while Tennessee public-health reporting confirms that medetomidine has appeared in parts of the state’s drug supply.
For someone struggling with fentanyl dependence, the next step is an individualized assessment that identifies immediate medical risks and determines the appropriate treatment setting.
Live Again Detox provides medically supervised addiction treatment in Nashville and can help individuals and families discuss fentanyl detox, residential treatment, insurance verification, and appropriate next steps after medical stabilization.
Medical emergency: If someone has stopped breathing, is unresponsive, or has potentially life-threatening withdrawal symptoms, call 911 immediately. For questions about possible poisoning, Poison Control is available at 1-800-222-1222.
